Bradley Pharmaceuticals
Bradley Pharmaceuticals was a pharmaceutical company based in the United States. It was founded in 1985 by Daniel Glassman, a former pharmaceutical sales representative. The company was listed on the New York Stock Exchange under the ticker symbol "BDY". Bradley Pharmaceuticals primarily focused on the development and marketing of dermatology and gastroenterology products.
History
Bradley Pharmaceuticals was established in 1985 by Daniel Glassman. The company started with a focus on niche therapeutic markets, particularly dermatology and gastroenterology. Over the years, Bradley Pharmaceuticals expanded its product portfolio through a combination of internal development and acquisitions.
In 2000, Bradley Pharmaceuticals acquired Doak Dermatologics, a company specializing in dermatology products. This acquisition significantly expanded Bradley's dermatology product line.
In 2005, Bradley Pharmaceuticals acquired A. Aarons Inc., a company that specialized in generic prescription pharmaceuticals. This acquisition allowed Bradley to expand into the generic pharmaceutical market.
In 2008, Bradley Pharmaceuticals was acquired by Nycomed, a Swiss pharmaceutical company. The acquisition was valued at approximately $346 million.
Products
Bradley Pharmaceuticals developed and marketed a wide range of products, primarily in the fields of dermatology and gastroenterology. Some of their notable products included Zoderm, a prescription acne treatment, and AnaMantle, a hemorrhoid treatment.
Legacy
Bradley Pharmaceuticals left a significant impact on the pharmaceutical industry. The company's focus on niche markets allowed it to develop and market products that addressed specific patient needs. This strategy proved successful, as evidenced by the company's growth and eventual acquisition by Nycomed.
See also
This article is a pharmacology-related stub. You can help WikiMD by expanding it!
Logo of Bradley Pharmaceuticals
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
